baber/WOPTO huggingface dataset:
Patent AU-609223-B2 (AU)
Title: Belt
Inventor: COOK CLIFTON L
IPC: A45C13/30
Filed: 1988-09-30
Granted: 1991-04-26
Abstract: A belt is disclosed which may be used for support, comfort and/or decoration, and has particular application in weight lifting, kidney support or other protection and which is of a construction utilizing a plurality of layers, one of which is of an elastically yieldingly compressible and shape-restoring material.
Patent AU-728023-B2 (AU)
Title: Apparatus and method for the continuous conversion of a cellulosic material to ethanol
Inventor: TITMAS JAMES A
IPC: C12M1/40
Filed: 1997-04-24
Granted: 2001-01-04
Abstract: Cellulosic material is converted to ethanol by hydrolyzing the cellulosic material in a gravity pressure vessel (50), and fermenting the product thereof. The gravity pressure vessel (50) employed is adapted to accommodate a continuous hydrolysis reaction and maximize the fermentable product yield on a commercial scale. The gravity pressure vessel (50) employed is also adapted to maximize the thermodynamic efficiencies of the hydrolysis reaction, as well as the entire ethanol producing process.
Patent AU-771936-B2 (AU)
Title: Felbamate derived compounds
Inventor: MACDONALD TIMOTHY L
IPC: C07D265/06
Filed: 2000-02-08
Granted: 2004-04-08
Abstract: The present invention relates to novel felbamate derivatives and their use to treat neurological diseases such as epilepsy and to treat tissue damage resulting form ischemic events. The felbamate derivatives are modified to prevent the formation of metabolites that are believed responsible for the toxicity associated with felbamate therapy.
Patent AU-754306-B2 (AU)
Title: Coating composition
Inventor: HUYNH-BA GIA
IPC: C08G18/65
Filed: 2001-03-26
Granted: 2002-11-14
Abstract: The present invention relates to coating compositions which can be used as the clear coat for automotive finishing or refinishing, the coating composition contining a film-forming binder which contains (A) hydroxyl-containing acrylic polymer and polyhydroxyl-tertiary amine, (B) organic polyisocyanate, and (C) catalyst, to provide a coating film which is quick to cure at ambient temperature.
Patent AU-559719-B2 (AU)
Title: Composite tape laying machine and method
Inventor: GRONE ROBERT JOSEPH
IPC: B29C70/00
Filed: 1984-08-29
Granted: 1987-03-19
Abstract: An improved method and apparatus for compacting a composite tape tail which is formed by making a cut along an oblique line across the tape (2) and manipulating first and second compaction means (20,33). The cut, however, severs only the tape (22) while it is adhered to the backing (24) but does not sever the backing (24) or subjacent support (which is usually a strip of paper). The backing is then peeled away from the strip at a location between the first compaction means (shoe. blade or pad (20)) and a second compaction means (preferably a roller (33)) and conveys the discarded portion of tape to storage, disposal etc. The first compaction means (20) bears down on the assembly (2) of the tape and backing. The second compaction means (33) engages the tape (22) after the peeling away. hence bears down on only the tail (18). Only one compaction means is used at a time. The second compaction means (33) compactingly engages the tail (18) not later than the arrival of the tail leading edge (52) at said second means by which time the first compacting means (20) has stopped compacting. Power means, such as an air cylinder (44,144) move or switch the two compaction means into and out of respective positions for compaction so that the full width tape is compacted by the first compaction means and the tail (oblique strip without any backing) is compacted by the second compaction means.
Patent AU-777988-B2 (AU)
Title: Peroral gene therapy of diabetes and obesity
Inventor: DURING MATTHEW J
IPC: A61K35/76
Filed: 2000-02-22
Granted: 2004-11-11
Abstract: The invention provide methods and compositions for targeting endocrine cells capable of converting an immature expressed protein into a mature protein, and secreting the expressed protein into the systemic circulation. In particular, the invention features methods and compositions for treating disorders, such as diabetes by orally administering a vector expressing insulin to target cells which can subsequently secrete the expressed insulin into the blood circulation.
Patent AU-773803-B2 (AU)
Title: Plug for insertion into a bone canal
Inventor: HESSELING SARET CORNELIS
IPC: A61F2/30
Filed: 2001-02-19
Granted: 2004-06-10
Abstract: A plug for insertion into a bone canal is disclosed. The plug comprises an elongate central body of substantially constant cross section carrying at least four radially extending flanges of substantially equal shape and size. The flanges form solid, disk-like structures, free of cuts and are axially spaced along the central axis of the body, such that they extend in substantially parallel planes. The plug is made of a copolymer of a polyalkylene glycol terephthalate and an aromatic polyester.
Patent AU-775332-B2 (AU)
Title: Novel phosphorus-containing prodrugs
Inventor: ERION MARK D
IPC: C07F9/6584
Filed: 2000-03-03
Granted: 2004-07-29
Abstract: Novel cyclic phosphoramidate prodrugs of drugs of formula (I), their use in delivery of drugs to the liver, their use in enhancing oral bioavailability, and their method of preparation are described.
Patent AU-632489-B2 (AU)
Title: Dual-column, dual-detector gas detector and analyzer
IPC: G01N30/78
Filed: 1989-07-20
Granted: 1993-01-07
Abstract: A dual-column, dual-detector gas detector and analyzer employs both a photo-ionization detector and a flame-ionization detector. In a survey mode, samples of ambient air are driven through both detectors, and the outputs of both detectors are used to determine the presence of one or more gasses. In analysis mode, fixed-volume samples of ambient air are driven through two elution columns having different properties. The output of each elution column is fed to one of the detectors. The arrival times of gas peaks at the two detectors are employed to develop two lists of candidate gasses. The lists are cross-checked for the presence of each candidate on both lists. Candidates identified from their presence on both lists are identified. A further check attempts to identify candidates which are identifiable from their presence on one of the lists, and not on the other. Components identified in this way are added to the final list. Unidentified components are discarded, although their presence is noted and reported as unknown. Portability is retained by eliminating isothermal ovens and by reducing the quantity of hydrogen required. A simplified way of characterizing temperature corrections of elution columns is disclosed.
Patent AU-702463-B2 (AU)
Title: Low rigidity liposomal antibacterial composition
Inventor: LAGACE JACQUELINE
IPC: C07H15/23
Filed: 1995-12-22
Granted: 1999-02-25
Abstract: The invention relates to a liposomal formulation containing a therapeutic agent. The formulation of the invention when administered to animals, allows a substantial increase in antibacterial activity of the agent, through an enhanced penetration of the agent inside the bacterial cell. More specifically, the invention relates to a liposomal formulation containing at least one therapeutic agent such as an antibiotic and to a method of treatment of bacterial infections through the administration of such a formulation.
Patent AU-576243-B2 (AU)
Title: Process for the continuous production of alcohols
Inventor: NEIER WILHELM
IPC: C07C31/12
Filed: 1985-05-20
Granted: 1988-08-18
Abstract: A method is provided for the continuous production of isopropanol and secondary butyl alcohol by catalytically hydrating the corresponding aliphatic olefin in an elongated reaction vessel in which co-product by-product dialkyl ether is separated from the reaction product and recycled to the reaction mixture being introduced therein at a point between the olefin feed inlet and the product outlet about 5 to 30 percent of the distance before the product outlet.
Patent AU-743884-B2 (AU)
Title: Metering valve and fuel supply system equipped therewith
Inventor: BRINK ALFRED VAN DEN
IPC: F16K31/06
Filed: 1999-06-09
Granted: 2002-02-07
Abstract: The invention relates to a metering valve for a fluid, provided with a housing with a metering opening and a movable closing member. The closing member is biased to one of its positions by biasing means co-acting therewith in the form of a pneumatic or hydraulic spring, and can be placed in another position counter to the bias by operating means. The pneumatic or hydraulic spring can herein be driven by the fluid for metering. The closing member can be a diaphragm with a relatively stiff central portion and a relatively flexible edge portion. A supply opening connected to a feed conduit for the fluid for metering can be arranged in the housing on either side of the diaphragm. The invention further relates to a system for supplying fuel to a combustion engine, provided with a container for the fuel and a feed line connecting the container to the engine, in which line is received one or more metering valves of the above described type. <IMAGE>
Patent AU-638220-B2 (AU)
Title: Provision of density specific blood cells for the structuredness of the cytoplasmic matrix (scm) test
IPC: G01N33/50
Filed: 1989-10-17
Granted: 1993-06-24
Abstract: An improved method is provided for the isolation of lymphocytes for use in the SCM test for the detection of cancer and other diseases and conditions. The method of the present invention can isolate either or both of the SCM-responding lymphocyte fractions from the same blood sample: the F2 fraction, with a buoyant density of 1.0590 g/cm<3> to 1.0670 g/cm<3> measured at 20 DEG C in a solution having an osmolality of about 0.315 Osm/kg, and the F4 fraction, with a buoyant density of 1.0690 g/cm<3> to 1.0730 g/cm<3>. These lymphocyte fractions are isolated in visible bands and are substantially free of lymphocytes having other buoyant densities. This avoids cross-contamination of the lymphocyte fractions with each other as well as with SCM non-responding lymphocytes. Several gradients useful in this isolation method are described. This isolation method can use as starting material either a blood sample depleted of phagocytic cells or the total population of lymphocytes. The latter avoids the use of iron powder or carbonyl-iron powder in removing the phagocytic cells.
Patent AU-698933-B2 (AU)
Title: Crosslinked polymers containing photoinitiators
Inventor: MULLER BEAT
IPC: C08J3/24
Filed: 1996-01-23
Granted: 1998-11-12
Abstract: PCT No. PCT/EP96/00253 Sec. 371 Date Sep. 12, 1997 Sec. 102(e) Date Sep. 12, 1997 PCT Filed Jan. 23, 1996 PCT Pub. No. WO96/24077 PCT Pub. Date Aug. 8, 1996The invention relates to a novel process for the production of mouldings, in particular contact lenses, in which a crosslinkable polymer comprising units containing crosslinkable groups, units containing a bound photoinitiator and, if desired, units containing further modifiers is crosslinked in solution, and to mouldings, in particular contact lenses, obtainable by this process. The present invention likewise relates to novel crosslinkable polymers which can be employed in the process, in particular derivatives of a polyvinyl alcohol having a molecular weight of at least about 2000 which comprises from about 0.5 to about 80%, based on the number of hydroxyl groups in the polyvinyl alcohol, of units of the formula I in which the variables are as defined in the description, and units of the formula IV, as defined in the description, which contain a bound photoinitiator.
Patent AU-675807-B2 (AU)
Title: Photochromic compounds
Inventor: RICKWOOD MARTIN
IPC: C08L25/06
Filed: 1993-11-23
Granted: 1997-02-20
Abstract: Photochromic materials which have a structure which includes a spiro-pyrrolidinebenzoxazine structure comprising a pyrrolidine part and a benzoxazine part and the benzoxazine part includes at least one mesomeric electron donating group chosen from amino and alkoxy moieties, the one or more mesomeric electron donating groups being linked to the 6' position via attachment to a conjugated system in which the unsaturated bonds forming the linkage are chosen from -C=C-, -C IDENTICAL C-, -C=N- and -N=N-.
Patent AU-757987-B2 (AU)
Title: Method and system for aiding GPS receivers via a cellular or PCS network
Inventor: BLOEBAUM LELAND SCOTT
IPC: H04W84/00
Filed: 1999-07-21
Granted: 2003-03-13
Abstract: In accordance with the invention, there is disclosed a system for determining location of a mobile station. The mobile station includes a transceiver operating in a wireless network and a GPS receiver. The system includes a wireless network control system including GPS receivers for obtaining ephemeris data. The control system develops assistance information from the ephemeris data and transmits the assistance information to the mobile station via the wireless network. The assistance information represents range at a fixed location in the wireless network in proximity to the mobile station at a select time, and derivatives of the range, relative to plural select satellites in the GPS. The mobile station utilizes received assistance information for searching the composite received signals from the plural select satellites in the GPS to measure a code phase for plural ones of the select satellites in the GPS and returning the measured code phases to the wireless network control system via the wireless network. The wireless network control system computes location of the mobile station in the wireless network utilizing a fixed location and the measured code phases.
Patent AU-763625-B2 (AU)
Title: Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient
Inventor: OKUI SHUKO
IPC: A01N43/58
Filed: 2000-06-28
Granted: 2003-07-31
Abstract: The invention provides a novel pest control agent having a high systemic activity and a high safety with reduced adverse influences on the environment neighboring the place to which the agent is applied, and a process for producing the same. Namely, the present invention relates to a novel 1-aryl-3-cyano-5-heteroarylalkylaminopyrazole derivative represented by the following general formula (1) and a process for producing the same, and a pest control agent containing the same as an active ingredient. <CHEM> (wherein X represents N or C-halogen, R<1> represents an alkyl group, an alkenyl group, an alkynyl group, or a haloalkyl group, R<2> represents hydrogen atom, an alkyl group, or an acyl group, R<3> represents hydrogen atom or an alkyl group, A represents any one of the groups represented by A-1 to A-4, R<4> represents hydrogen atom, an alkyl group, a halogen atom, and n represents 0, 1, or 2, provided that R<1> is a haloalkyl group except a perhaloalkyl group when A is A-1 and n is 0, and that n is not 0 when A is A-4.).
Patent AU-763365-B2 (AU)
Title: Infant safety device
Inventor: MORGILLO ANGELO
IPC: A47D15/00
Filed: 1999-08-25
Granted: 2003-07-17
Abstract: A safety device (2) for use in safely restraining an infant, particularly on a flat substrate, is described, the safety device (2) comprising a support portion (4) for supporting the body of the infant and a harness portion (20) for restraining the body of the infant in the supported position in which the harness (20) includes a number of flaps (16, 22, 24, 28) which co-operate with each other to envelop a part of the body of the infant, thereby restraining the infant. The device may be in the form of a U-pillow or in the form of a pillowcase for a U-pillow. In addition, the device is provided with a pocket (14) for storing the harness when not in use and for acting as a neck, head or shoulder rest by providing an extra thickness of padding.
Patent AU-578833-B2 (AU)
Title: Improved heat transfer tube having internal ridges, and method of making same
Inventor: CUNNINGHAM JAMES LEE
IPC: B21C37/20
Filed: 1986-06-11
Granted: 1988-11-03
Abstract: A heat transfer tube (10) has mechanical enhancements which improve the heat transfer properties of at least the outer (12) surface of the tube. An optional internal enhancement, which is useful on either boiling or condensing tubes, comprises a plurality of closely spaced helical ridges (16) which provide increased surface area and are positioned at an angle which gives them a tendency to swirl liquid flowing through the tube. The external enhancement, which is applicable to boiling tubes, is provided by successive cross-grooving and rolling operations performed after finning. The finning operation, in a preferred embodiment for nucleate boiling, produces fins while the cross-grooving and rolling operation deforms the tips of the fins and causes the surface of the tube to have the general appearance of a grid of generally rectangular flattened blocks (see Figure 8) which are wider than the fins and separated by narrow openings (20) between the fins and narrow grooves normal thereto. The roots of the fins and the cavities or channels formed therein under the flattened fin tips are of much greater width than the surface openings so that the vapour bubbles can travel outwardly through the cavity and to and through the narrow openings. The cavities and narrow openings and the grooves all cooperate as part of a flow and pumping system so that the vapour bubbles can readily be carried away from the tube and so that fresh liquid can circulate to the nucleation sites. The rolling operation is performed in a manner such that the cavities produced will be both larger and smaller than the optimum minimum pore size for nucleate boiling of a particular fluid under a particular set of operating conditions.
Patent AU-518722-B2 (AU)
Title: Vibrator system
Inventor: FAIR D W
IPC: G01V1/02
Filed: 1980-07-30
Granted: 1981-10-15
Abstract: A carrier mounted seismic vibrator system that is primarily adapted for generation of high force, high frequency seismic energy into an earth medium. The apparatus includes first and second vibrators (12F and R) as supported byfirst and second lift systems (28F and R) disposed in tandem juxtaposition generally centrally in said vehicle (10), and the lift systems (28F and R) are designed to maintain equal hold-down force on the vibrator coupling baseplates (32F and R) without exceeding the weight of the carrier vehicle. The juxtaposed vibrators are then energized in synchronised relationship to propagate increased amounts of higher frequency seismic energy into an earth medium.
Patent AU-605105-B2 (AU)
Title: Inhibin and method of purifying same
Inventor: LING NICHOLAS CHAI-KWAN
IPC: A61K38/00
Filed: 1986-07-17
Granted: 1991-01-10
Abstract: Two 32,000-dalton proteins with inhibin activity were isolated from porcine follicular fluid using heparin-Sepharose affinity chromatography, followed by gel filtration on Sephacryl S-200 and then four steps of reverse-phase high-performance liquid chromatography. Each isolated molecular is composed of two chains having molecular weights of about 18,000 and about 14,000 daltons, respectively, which are bound together by disulfide bonding. Microsequencing revealed the NH2-terminal portion of the 18K chain of both to be Ser-Thr-Ala-Pro-Leu-Pro-Trp-Pro-Trp-Ser-Pro-Ala-Ala-Leu-Arg-Leu-Leu-Gl n-Arg-Pro-Pro-Glu-Glu-Pro-Ala-Val, of one of the 14K chains to be Gly-Leu-Glu-Cys-Asp-Gly-Arg-Thr-Asn-Leu-Cys-Cys-Arg-Gln-Gln-Phe-Phe-Il e-Asp-Phe-Arg-Leu-Ile-Gly-Trp, and of the other 14K chain to be Gly-Leu-Glu-Cys-Asp-Gly-Lys-Val-Asn-Ile-Cys-Cys-Lys-Lys-Gln-Phe-Phe-Va l-Ser-Phe-Lys-Asp-Ile-Gly-Trp-Asn-Asp-Trp-Ile-Ile-Ala-Pro. Both proteins have now been completely characterized, each having a first chain 134 residues long linked by disulfide bonding to a second chain 116 or 115 residues long. The first chain is believed to be glycosylated, which accounts for the disparity between the number of residues and the apparent molecular weight of 18K. These 32K proteins specifically inhibit basal secretion of FSH, but not of LH, in a rat anterior pituitary monolayer culture system. The half-maximal effective does of one is 450 pg/ml and of the other is 900 pg/ml.
Patent AU-642432-B2 (AU)
Title: Method and apparatus for chlorine dioxide manufacture
Inventor: ROSENBLATT AARON A
IPC: B01D53/00
Filed: 1990-09-17
Granted: 1993-10-21
Abstract: A method and apparatus for the generation, use, and disposal of chlorine dioxide is disclosed. A solid sodium chlorite composition having impurities, at least one of which is sodium hydroxide, is contacted with an agent to consume essentially all of the sodium hydroxide. Chlorine dioxide gas is then generated by contacting the resultant composition with chlorine in a humidified inert carrier gas. The resultant chlorine dioxide gas mixture may then be treated to remove chlorine gas present therein by contacting the same with soda-lime in particulate form. After using the chlorine dioxide gas mixture in the desired manner, chlorine dioxide present in the spent effluent gas may be substantially removed via the introduction of the effluent gas into an aqueous solution of sodium thiosulfate having a sufficient amount of an inorganic base to maintain the alkalinity of the solution during consumption of thiosulfate by chlorine dioxide.
Patent AU-703091-B2 (AU)
Title: Monoclonal antibodies against soluble TNF-alpha receptors p55 and p75 as well as against TNF-alpha and its analogues
Inventor: SERBEC VLADKA CURIN
IPC: C07K14/715
Filed: 1996-07-31
Granted: 1999-03-18
Abstract: The present invention belongs to the field of pharmaceutical industry and relates to novel monoclonal antibodies and fragments thereof which are bound to the available surface of a human recombinant TNF- alpha , TNF- alpha  analogues and TNF- alpha  soluble receptors p55 and p75. Further, the invention relates to stable hybridoma cell lines, which lines are capable of producing such monoclonal antibodies, to a process for the preparation thereof and to pharmaceutical preparations containing them. The invention also relates to a method for the quantitative determination of human TNF- alpha , free or complexed with soluble TNF- alpha  receptors p55 and p75, and to a kit used therefor. By hitherto disclosed monoclonal antibodies and reagents developed therefrom, it has not been possible to simultaneously determine free TNF- alpha  and its soluble receptors p55 and p75 as well as complexes thereof. Another object of the invention is also the TNF- alpha  analogue TNF- alpha  Cys95His107His108Cys148, which in a complex with TNF- alpha  soluble receptors, is used as an antigen for immunization of mice.